Article Information
History
- February 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ana Luiza Valle Martins1,#,
- Filipe Alex da Silva2,#,
- Lucas Bolais-Ramos2,#,
- Gisele Capanema de Oliveira2,
- Renata Cunha Ribeiro2,
- Danilo Augusto Alves Pereira2,3,
- Filippo Annoni4,
- Mirella Monique Lana Diniz2,
- Thuanny Granato Fonseca Silva2,
- Bruna Zivianni5,
- Alexandre Carvalho Cardoso2,
- Juliana Carvalho Martins5,
- Daisy Motta-Santos2,
- Maria José Campagnole-Santos2,
- Fabio Silvio Taccone4,
- Thiago Verano-Braga2 and
- Robson Augusto Souza Santos2,*
- 1Hospital Mater Dei, Intensive Care Unit, Belo Horizonte, Brazil
- 2National Institute of Science and Technology in Nano Biopharmaceutics (INCT-NanoBiofar)-Laboratory of Hypertension, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil
- 3Waters Corporation, São Paulo, Brazil
- 4Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
- 5Fundação Hospitalar do Estado de Minas Gerais – FHEMIG, Belo Horizonte, Brazil
- ↵*Corresponding author: Robson Santos, MD, PhD, National Institute of Science and Technology in Nanobiopharmaceutics (INCT-NanoBiofar) - Laboratory of Hypertension, Institute of Biological Sciences, Federal University of Minas Gerais; email: robsonsant{at}gmail.com
↵# These authors contributed equally.
Posted February 03, 2021.
Increased circulating levels of angiotensin-(1-7) in severely ill COVID-19 patients
